Hope or hype :the obsession with medical advances and the high cost of false promises
- 作者: Deyo, Richard A.
- 其他作者: Patrick, Donald L.
- 出版: New York : AMACOM, American Management Association ©2005.
- 稽核項: 1 online resource (xvi, 335 pages) :illustrations.
- 標題: Medical care Technological innovations -- United States -- Evaluation. , TECHNOLOGY & ENGINEERING , Medical innovations , MEDICAL Biotechnology. , Medical care, Cost of United States. , Medical care Evaluation. , Évaluation. , Technologie médicale États-Unis -- Évaluation. , Medical innovations United States -- Evaluation. , Medical technology Cost effectiveness. , Technological innovationsCost effectiveness. , TECHNOLOGY & ENGINEERING Biomedical. , MEDICAL Family & General Practice. , MEDICAL Allied Health Services -- Medical Technology. , Medical care Technological innovations -- United States -- Cost effectiveness. , InnovationsÉvaluation. , Medical innovations Economic aspects -- United States. , Medical care United States -- Evaluation. , Biotechnology. , Soins médicaux Coût -- États-Unis. , Medical innovations Economic aspects. , Electronic book. , Biomedical. , Medical technology United States -- Cost effectiveness. , Médecine Innovations -- États-Unis -- Évaluation. , MEDICAL , Cost effectiveness. , Technologie médicale , MEDICAL Lasers in Medicine. , Medical technology , Medical innovations Evaluation. , Lasers in Medicine. , Electronic books. , Medical care , Allied Health ServicesMedical Technology. , Medical care, Cost of. , Médecine , Medical care, Cost of , Medical technology United States -- Evaluation. , Technological innovationsEvaluation. , Evaluation. , Andre fag (naturvidenskab og teknik) Andre fag , InnovationsAspect économique , Médecine Innovations -- Aspect économique -- États-Unis. , Technologie médicale États-Unis -- Coût-efficacité. , Family & General Practice. , Coût , Medical technology Evaluation. , United States. , Soins médicaux , Economic aspects. , Economic aspects , Coût-efficacité.
- ISBN: 0814408451 , 9780814408452
- 試查全文@TNUA:
- 附註: Includes bibliographical references (pages 291-326) and index. Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured -- film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
- 摘要: Annotation
- 電子資源: https://dbs.tnua.edu.tw/login?url=https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=117775
- 系統號: 005315022
- 資料類型: 電子書
- 讀者標籤: 需登入
- 引用網址: 複製連結
"Hope or Hype outlines the hazards - from unnecessary treatment to actual harm or even death - of embracing medical advances without serious consideration of efficacy, long-term benefit, side effects, cost, and other critical factors. The book also provides a frank and sometimes startling look at how companies get us to buy into the need for the most expensive treatments, and even manipulate clinical trials and data in order to present the "right" result."--Jacket.
來源: Google Book
來源: Google Book
評分